# Aspire Biopharma Holdings, Inc. (ASBP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ASBP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 6.4K | $ -25.07M | $ -5.04M | $ 1.38M | $ -6.38M |
| 2024 | $ 0 | $ -13.18M | $ -278.7K | $ 1.27M | $ -1.54M |
| 2023 | $ 0 | $ 4.83M | $ -706.2K | $ 12.4K | $ 19.58M |
| 2022 | $ 0 | $ 3.73M | $ -1.57M | $ 28.0K | $ 289.07M |
| 2021 | $ 0 | $ -31.1K | $ 160.0K | $ 238.6K | $ -475 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.22 |
| Liabilities / Eq | -1.21 |
| Current Ratio | 0.17 |

## Other views

- [Metrics](https://sponda.capital/en/ASBP.md)
- [Charts](https://sponda.capital/en/ASBP/charts.md)
- [Compare](https://sponda.capital/en/ASBP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.